Sami Corwin
Stock Analyst at William Blair
(0)
# 4907
Out of 5,217 analysts
9
Total ratings
0.00%
Success rate
-30.67%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cargo Therapeutics | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 26, 2024 | |
Tenaya Therapeutics | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 10, 2024 | |
Neurogene | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Mar 21, 2024 | |
Mesoblast | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 4, 2023 | |
CRISPR Therapeutics | Reinstates: Outperform | 75 | 44.58 | 68.24% | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 66 | 17.46 | 278.01% | 1 | Oct 27, 2021 |